SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden
SWEtick
Emerging Tick-borne Diseases in Children and Adults in Sweden (SWEtick): a Prospective Multicenter Study for Improved Patient Management
1 other identifier
observational
600
1 country
12
Brief Summary
The purpose of the SWEtick project is to increase the knowledge of the various clinical presentations of emerging tick-borne diseases (eTBD), to assess their importance for human health, to develop and validate laboratory methods for diagnosis of eTBD, and to develop recommendations for knowledge-driven management of patients with suspected eTBD within the Swedish healthcare system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Longer than P75 for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 8, 2025
CompletedFirst Posted
Study publicly available on registry
January 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2035
March 5, 2026
March 1, 2026
7.3 years
January 8, 2025
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
EuroQoL-5 Dimension Questionnaire (EQ-5D)
Difference in EQ-5D Health index between study inclusion and at the 6 month-follow-up
6 months
Visual Analogue Scale for Health (VAS)
Difference between the VAS units at study inclusion and at 6 month-follow-up.
6 months
Study Arms (5)
TBD
Patients with confirmed tick-borne disease
Non-TBD
Patients investigated for suspected tick-borne disease but diagnosed with another condition (tick-borne disease excluded)
Control group CNS
Patients obtaining spinal anasthesia in conjunction with knee or hip replacement surgery due to arthrosis
Control group arthritis
Patients with autoinflammatory joint disease
Control group healthy
Blood donors
Eligibility Criteria
1. Medical history: tick exposure, tick bite, splenectomy, immunosuppressive treatment (e.g. anti-CD20 or other biological/immunomodulatory drugs, cortisone corresponding to \>10 mg prednisolone/day, chemotherapy, hematologic malignancy, other malignancy, rheumatologic disease) 2. Symptoms/clinical signs: fever after tick bite, relapsing fever of unknown origin, skin rashes (single/multiple erythema migrans, lymphocytoma, acrodermatitis chronica atrophicans or other), venous thrombosis, repeated thrombophlebitis, meningitis, encephalitis, myelitis, cranial nerve palsy, radiculitis, peripheral nerve involvment, mono-/oligoarthritis, carditis, ocular or otogenic disturbances of uncertain origin where medical history includes recent tick bite. 3. Biochemical findings in combination with factors under a) and b): leukopenia, thrombocytopenia, anemia, elevated liver enzymes, slightly elevated erythrocyte sedimentation rate and/or C-reactive protein, pleocytosis in CSF or synovial fluid.
You may qualify if:
- Clinical suspicion of tick-borne disease (physician's assessment based on medical history, symptoms, clinical findings and sometimes laboratory results)
You may not qualify if:
- Incapacitated to understand the study information and make decisions (adults and adolescents \>15 years)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Jönköping Countylead
- Region of Uppsalacollaborator
- Region Örebro Countycollaborator
- Västra Götalandsregionencollaborator
- Region Östergötlandcollaborator
- Region Kalmar Countycollaborator
- Region Dalarnacollaborator
- FORSS - The Research Council of South-Eastern Swedencollaborator
- ALF Grants, Region Östergötlandcollaborator
- Linkoeping Universitycollaborator
Study Sites (12)
Department of Paediatrics
Falun, Region Dalarna, Sweden
Department of Paediatrics, Eksjö Hospital
Eksjö, Region Jönköping County, 575 81, Sweden
Department of Infectious Diseases, County Hospital Ryhov
Jönköping, Region Jönköping County, 55185, Sweden
Department of Paediatrics
Jönköping, Region Jönköping County, 55185, Sweden
Department of Infectious Diseases, Kalmar County Hospital
Kalmar, Region Kalmar County, 392 56, Sweden
Department of Infectious Diseases
Uppsala, Region Uppsala, Sweden
Department of Paediatrics
Uppsala, Region Uppsala, Sweden
Department of Paediatrics
Örebro, Region Örebro County, Sweden
Department of Infectious Diseases, Linköping University Hospital
Linköping, Region Östergötland, 581 85, Sweden
Department of Infectious Diseases, Vrinnevi Hospital
Norrköping, Region Östergötland, 603 79, Sweden
Department of Paediatrics, Vrinnevi Hospital
Norrköping, Region Östergötland, 603 79, Sweden
Department of Paediatrics
Skövde, Västra Götalandsregionen, Sweden
Related Publications (9)
Henningsson AJ, Asgeirsson H, Hammas B, Karlsson E, Parke A, Hoornstra D, Wilhelmsson P, Hovius JW. Two Cases of Borrelia miyamotoi Meningitis, Sweden, 2018. Emerg Infect Dis. 2019 Oct;25(10):1965-1968. doi: 10.3201/eid2510.190416.
PMID: 31538916BACKGROUNDUhnoo I, Cars O, Christensson D, Nystrom-Rosander C. First documented case of human babesiosis in Sweden. Scand J Infect Dis. 1992;24(4):541-7. doi: 10.3109/00365549209052642.
PMID: 1411322BACKGROUNDEimer J, Fernstrom L, Rohlen L, Grankvist A, Loo K, Nyman E, Henningsson AJ, Haglund M, Hultqvist V, Sjowall J, Wenneras C, Schon T. Spiroplasma ixodetis Infections in Immunocompetent and Immunosuppressed Patients after Tick Exposure, Sweden. Emerg Infect Dis. 2022 Aug;28(8):1681-1685. doi: 10.3201/eid2808.212524.
PMID: 35876734BACKGROUNDBjoersdorff A, Berglund J, Kristiansen BE, Soderstrom C, Eliasson I. [Varying clinical picture and course of human granulocytic ehrlichiosis. Twelve Scandinavian cases of the new tick-borne zoonosis are presented]. Lakartidningen. 1999 Sep 29;96(39):4200-4. Swedish.
PMID: 10544585BACKGROUNDNilsson K, Elfving K, Pahlson C. Rickettsia helvetica in patient with meningitis, Sweden, 2006. Emerg Infect Dis. 2010 Mar;16(3):490-2. doi: 10.3201/eid1603.090184.
PMID: 20202426BACKGROUNDNilsson K, Lindquist O, Pahlson C. Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet. 1999 Oct 2;354(9185):1169-73. doi: 10.1016/S0140-6736(99)04093-3.
PMID: 10513711BACKGROUNDWenneras C, Wass L, Bergstrom B, Grankvist A, Lingblom C. Ten years of detecting Neoehrlichia mikurensis infections in Sweden: demographic, clinical and inflammatory parameters. Eur J Clin Microbiol Infect Dis. 2024 Nov;43(11):2083-2092. doi: 10.1007/s10096-024-04909-5. Epub 2024 Aug 13.
PMID: 39136831BACKGROUNDQuarsten H, Henningsson A, Krogfelt KA, Strube C, Wenneras C, Mavin S. Tick-borne diseases under the radar in the North Sea Region. Ticks Tick Borne Dis. 2023 Jul;14(4):102185. doi: 10.1016/j.ttbdis.2023.102185. Epub 2023 Apr 26.
PMID: 37116420BACKGROUNDHenningsson AJ, Aase A, Bavelaar H, Flottorp S, Forsberg P, Kirkehei I, Lovmar M, Nilsson K, Nyman D, Ornstein K, Sjowall J, Skogman BH, Tjernberg I, Aaberge I. Laboratory Methods for Detection of Infectious Agents and Serological Response in Humans With Tick-Borne Infections: A Systematic Review of Evaluations Based on Clinical Patient Samples. Front Public Health. 2021 Sep 20;9:580102. doi: 10.3389/fpubh.2021.580102. eCollection 2021.
PMID: 34616701BACKGROUND
Related Links
Biospecimen
Whole blood, skin biopsies, cerebrospinal fluid, synovial fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Consultant, Senior Associate Professor
Study Record Dates
First Submitted
January 8, 2025
First Posted
January 17, 2025
Study Start
September 1, 2023
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
December 1, 2035
Last Updated
March 5, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
All IPD that underlie results in a publication can be shared after anonymization, upon request